Učitavanje...
Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
The treatment of metastatic renal cell carcinoma (mRCC) has evolved markedly over the past several decades; first with the introduction of targeted therapies and more recently with data supporting checkpoint inhibition. However, the vast majority of studies to date have explored the benefit of agent...
Spremljeno u:
| Izdano u: | Kidney Cancer |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
IOS Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6179117/ https://ncbi.nlm.nih.gov/pubmed/30334011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/KCA-170019 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|